NAS:SLS (USA) Also trade in: Germany

SELLAS Life Sciences Group Inc

$ 0.13 0 (-3.36%)
Volume: 21,091,530 Avg Vol (1m): 16,186,949
Market Cap $: 28.61 Mil Enterprise Value $: 14.63 Mil
P/E (TTM): 0.00 P/B: 0.98
Earnings Power Value 1.41
Net Current Asset Value -0.38
Tangible Book -0.33
Projected FCF -11.65
Median P/S Value 0
Graham Number 0
Peter Lynch Value 0
DCF (FCF Based) 0
DCF (Earnings Based) 0
1Y (-%)

Financial Strength : 4.2/10

GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
Current vs industry vs history
Cash-to-Debt 5.47
Cash-To-Debt range over the past 10 years
Min: 0.17, Med: 23.63, Max: 10000
Current: 5.47
0.17
10000
Debt-to-Equity 0.16
Debt-to-Equity range over the past 10 years
Min: -7.34, Med: 0.06, Max: 5.31
Current: 0.16
-7.34
5.31
Debt-to-EBITDA -0.02
Debt-to-EBITDA range over the past 10 years
Min: -0.53, Med: -0.14, Max: 0
Current: -0.02
-0.53
0
Piotroski F-Score 2
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -13.02
DISTRESS
GREY
SAFE
WACC vs ROIC %
ROIC -775.87%
WACC 4.83%

Profitability & Growth : 4/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
Current vs industry vs history
ROE % -793.49
ROE range over the past 10 years
Min: -1127.85, Med: -378.76, Max: -170.48
Current: -793.49
-1127.85
-170.48
ROA % -89.17
ROA range over the past 10 years
Min: -221.38, Med: -94.32, Max: -39.93
Current: -89.17
-221.38
-39.93
ROC (Joel Greenblatt) % -31596.60
ROC (Joel Greenblatt) range over the past 10 years
Min: -31596.6, Med: -4024.51, Max: -1190.88
Current: -31596.6
-31596.6
-1190.88
3-Year Total EBITDA Growth Rate 3.00
3-Year EBITDA Growth Rate range over the past 10 years
Min: -76.4, Med: 31.25, Max: 73.8
Current: 73.8
-76.4
73.8
3-Year EPS w/o NRI Growth Rate 72.40
3-Year EPS w/o NRI Growth Rate range over the past 10 years
Min: 0, Med: 23.4, Max: 72.4
Current: 72.4
0
72.4

» SLS's 30-Y Financials

Financials (Next Earnings Date: 2019-08-15)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NAS:SLS

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Biotechnology » Biotechnology    NAICS : 325412    SIC : 2834
Compare XSAT:NXTCL NAS:CUR OTCPK:NBIO ROCO:4135 XPAR:ALHYG ASX:VBS OTCPK:AURX NAS:EARS NAS:CYTX OSTO:FLUI TSXV:RP OTCPK:BRTX TSXV:RVV AMEX:BPMX OTCPK:WIZP BOM:524412 WAR:SCS OTCPK:PPCBD XSAT:ALTE ASX:SCU
Traded in other countries RXK2.Germany
Address 315 Madison Avenue, 4th Floor, New York, NY, USA, 10017
SELLAS Life Sciences Group Inc is a biopharmaceutical company. The company is engaged in the development of novel cancer immunotherapies for a broad range of cancer indications.

Ratios

Current vs industry vs history
PB Ratio 0.98
PB Ratio range over the past 10 years
Min: 0.01, Med: 2.12, Max: 128.44
Current: 0.98
0.01
128.44
EV-to-EBIT -0.49
EV-to-EBIT range over the past 10 years
Min: -24.9, Med: -0.3, Max: 1
Current: -0.49
-24.9
1
EV-to-EBITDA -0.49
EV-to-EBITDA range over the past 10 years
Min: -25.2, Med: -0.3, Max: 1
Current: -0.49
-25.2
1
Current Ratio 0.59
Current Ratio range over the past 10 years
Min: 0.33, Med: 1.32, Max: 11.02
Current: 0.59
0.33
11.02
Quick Ratio 0.59
Quick Ratio range over the past 10 years
Min: 0.33, Med: 1.3, Max: 11.02
Current: 0.59
0.33
11.02

Dividend & Buy Back

Current vs industry vs history
3-Year Share Buyback Rate -264.50
3-Year Share Buyback Rate range over the past 10 years
Min: -264.5, Med: -50.1, Max: -14.5
Current: -264.5
-264.5
-14.5

Valuation & Return

Current vs industry vs history
Earnings Yield (Joel Greenblatt) % -205.31
Earnings Yield (Greenblatt) range over the past 10 years
Min: -1889.8, Med: -6.5, Max: 2551.9
Current: -205.31
-1889.8
2551.9

More Statistics

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 2
Positive ROA N
Positive CFROA N
Higher ROA yoy N
CFROA > ROA N
Lower Leverage yoy Y
Higher Current Ratio yoy Y
Less Shares Outstanding yoy N
Higher Gross Margin yoy N
Higher Asset Turnover yoy N